Tularemia: Clinical Trials

6 trials for Tularemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 unknown, 1 withdrawn. 4 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Unknown 1, Withdrawn 1
Not applicable1Not yet recruiting 1

Follow Tularemia: new trials by email Literature Review of Tularemia trials Research Report on Tularemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Peripheral venous blood sample - Leishmaniasis, Leptospirosis
Not applicableNot yet recruitingUniversity Hospital, Montpellier1832025-03-032025-03-05
Seroprevalence of Leptospirosis in Val Müstair, Switzerland
Blood sample collection, Data collection - Leptospirosis, Hepatitis E Virus Infection
CompletedUniversity Hospital, Basel, Switzerland2582022-03-032024-12-13
FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4)
Live Attenuated Tularemia Vaccine - Tularemia
Phase 2WithdrawnU.S. Army Medical Research and Development Command2021-06-092023-08-21
Phase II Tularemia Vaccine Comparison
Placebo, Undiluted Francisella tularensis live attenuated vaccine - Tularaemia
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2282010-09-012016-01-13
Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
Live Francisella Tularensis Vaccine - Tularemia
Phase 2UnknownU.S. Army Medical Research and Development Command10002009-08-282021-04-29
Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
Live F tularensis Vaccine - Tularemia
Phase 2CompletedU.S. Army Medical Research and Development Command4842004-10-012020-01-02

Narrower conditions

Hepatitis E (2)  ·  Leptospirosis (2)  ·  Bacterial Infections (1)  ·  Brucellosis (1)  ·  Chikungunya Fever (1)  ·  Encephalitis, Tick-Borne (1)  ·  Hantavirus Pulmonary Syndrome (1)  ·  Leishmaniasis (1)  ·  Lyme Disease (1)  ·  Psittacosis (1)  ·  Q Fever (1)  ·  Rickettsia Infections (1)  ·  Zika Virus Infection (1)

Broader conditions

Bacterial Infections and Mycoses (6)  ·  Gram-Negative Bacterial Infections (6)  ·  Infections (6)  ·  Tick-Borne Diseases (6)  ·  Vector Borne Diseases (6)  ·  Bacterial Infections (5)  ·  Digestive System Diseases (2)  ·  Hepatitis (2)  ·  Hepatitis, Viral, Human (2)  ·  Liver Diseases (2)  ·  RNA Virus Infections (2)  ·  Spirochaetales Infections (2)  ·  Virus Diseases (2)  ·  Alphavirus Infections (1)  ·  Arbovirus Infections (1)

Interventions

Data Collection (1)

Sponsors

U.S. Army Medical Research and Development Command (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University Hospital, Montpellier (1)

Countries

United States (4)  ·  France (1)  ·  Switzerland (1)

Top investigators

Anthony Cardile, DO (1)  ·  Benjamin C Pierson, MD (1)  ·  Mark Goldberg, MD (1)  ·  Michael Osthoff, PD Dr. med. (1)

Results publications

PMID 28750854, PMID 36741404